Thyroid Nodules: Modern Diagnostics and Effective Treatment

Introduction: What Are Thyroid Nodules?

Thyroid nodules are localized formations within the thyroid tissue that differ in structure from the surrounding tissue. This is one of the most common endocrine pathologies, the frequency of which increases significantly with age. According to various studies, nodules are detected in 30-50% of the adult population, and when using high-sensitivity diagnostic methods, such as ultrasound examination, this figure can reach 70% [1]. Most of these formations are benign and do not pose a threat to life, but about 5-10% of them may be malignant or have the potential for malignancy [2].

The causes of nodule formation are diverse and not yet fully understood. These include dietary iodine deficiency, genetic predisposition, radiation exposure, chronic inflammatory processes in the thyroid gland (for example, autoimmune thyroiditis), as well as certain environmental and lifestyle factors. It is important to understand that the presence of a nodule is not always accompanied by impaired thyroid function, and many patients experience no symptoms [3]. However, large nodules can cause discomfort, a sensation of pressure in the neck area, difficulty swallowing or breathing, as well as a cosmetic defect.

Diagnosis of Thyroid Nodules: From Palpation to Biopsy

Effective diagnosis is the key to determining the nature of the nodule and choosing the optimal treatment strategy. The process begins with a thorough history taking and physical examination.

• Palpation and Thyroid Ultrasound: Initial examination includes palpation of the neck to identify enlarged lymph nodes and assess the size, consistency, and mobility of the thyroid gland. However, the most informative and accessible method is ultrasound examination (ultrasound) [4]. Ultrasound allows for the precise determination of the number, size, location, and structure of nodules (solid, cystic, mixed), the presence of calcifications and blood flow, and the assessment of regional lymph nodes. These characteristics play an important role in assessing the risk of malignancy.

• Laboratory Tests: A mandatory step is determining the level of thyroid-stimulating hormone (TSH) in the blood. Changes in TSH levels may indicate impaired thyroid function (hyperthyroidism or hypothyroidism), which is sometimes associated with nodular formations. When TSH levels deviate, additional tests for free fractions of thyroxine (free T4) and triiodothyronine (free T3), as well as antibodies to thyroid peroxidase (anti-TPO) and thyroglobulin (anti-TG), may be prescribed to rule out autoimmune diseases [5].

• Fine-Needle Aspiration Biopsy (FNAB): This is the main method for the differential diagnosis of benign and malignant nodules. FNAB is performed under ultrasound guidance, which ensures high precision in tissue sampling. The obtained cellular material is sent for cytological examination, the results of which are classified according to the Bethesda system [6]. This system standardizes the assessment and determines further strategy: from benign changes requiring observation to malignant ones requiring surgical intervention.

• Molecular Genetic Tests: In some cases, when FNAB results are ambiguous (for example, with atypia of undetermined significance or follicular neoplasia), molecular genetic testing may be recommended. They help assess the risk of malignancy by identifying specific mutations in the cells of the nodule, which avoids unnecessary surgeries or, conversely, timely provides the necessary treatment [7].

Risk Assessment and Nodule Classification

To standardize the assessment of ultrasound characteristics of nodules and determine indications for FNAB, the TIRADS (Thyroid Imaging Reporting and Data System) is used. This system assigns scores to nodules based on their size, shape, margins, echogenicity, presence of calcifications, and other features, allowing them to be classified into risk categories from TR1 (benign) to TR5 (high risk of malignancy) [8].

Based on the results of FNAB and ultrasound, nodules are divided into:

• Benign Nodules: Constitute the vast majority. They can be colloid, cystic, or adenomas. Usually, they require only active surveillance [1].

• Malignant Nodules: Include papillary, follicular, medullary, and anaplastic thyroid cancer. They require active treatment, most often surgical [2].

• Nodules with Indeterminate Potential: This is a group requiring additional diagnostics or closer monitoring. This includes nodules with atypia of undetermined significance or follicular neoplasia, where the risk of malignancy ranges from 10% to 40% [3].

Modern Approaches to the Treatment of Thyroid Nodules

The choice of treatment strategy depends on the nature of the nodule (benign or malignant), its size, functional activity, presence of symptoms, and the patient's general condition.

• Active Surveillance: Most benign nodules, especially small ones that cause no symptoms, require only regular ultrasound (every 6-12 months) and monitoring of TSH levels. The goal is to ensure there is no nodule growth or change in characteristics [4].

• Medication Therapy: For functionally active nodules causing hyperthyroidism, antithyroid drugs can be used. In the past, levothyroxine medications were widely used to suppress the growth of benign nodules, but their effectiveness in this context is limited and associated with the risk of side effects. Iodine-containing preparations may be recommended for iodine deficiency, but their use in already formed nodules requires caution and must be agreed upon with a doctor [5].

• Surgical Intervention: This is the main method of treatment for malignant nodules, as well as for large benign nodules causing compression symptoms or a significant cosmetic defect. The scope of surgery can range from removing part of a lobe (hemithyroidectomy) to complete removal of the thyroid gland (thyroidectomy) with possible removal of lymph nodes [6].

• Minimally Invasive Methods: For the treatment of benign nodules, especially cystic or solid ones that are not subject to observation, minimally invasive methods are actively developing. These include radiofrequency ablation (RFA) and laser ablation. These methods reduce the volume of the nodule by destroying its cells using heat, while preserving thyroid function and avoiding open surgery. They are especially relevant for patients with high surgical risk or those who prefer minimally invasive procedures [7].

• Radioactive Iodine Therapy (I-131): Used to treat functionally active (toxic) nodules causing hyperthyroidism, as well as after surgical removal of thyroid cancer to destroy residual cancer cells [8].

Living with Thyroid Nodules: Monitoring and Prevention

After a diagnosis is made and a treatment strategy is chosen, it is important to follow the doctor's recommendations. For patients with benign nodules, this means regular dynamic monitoring, including ultrasound and TSH control. If necessary, dietary correction (adequate iodine intake in deficient regions, but without excess) and lifestyle changes may be recommended [1].

For patients who have undergone thyroid removal surgery, lifelong levothyroxine hormone replacement therapy is mandatory. Regular monitoring of TSH levels and other indicators helps maintain normal metabolism and prevent disease recurrence [2].

Although it is impossible to completely prevent the formation of nodules, a healthy lifestyle, a balanced diet with an adequate but not excessive amount of iodine, avoiding radiation exposure, and timely medical consultation for any symptoms can contribute to early detection and successful treatment [3].

Sources

• [1] Treatment of chronic hand and foot eczema. An Australian/New Zealand clinical review. (The Australasian journal of dermatology, 2021) https://pubmed.ncbi.nlm.nih.gov/32776537/
• [2] Consensus statement on the management and treatment of Sturge-Weber syndrome: neurology, neuroimaging, and ophthalmology recommendations. (Pediatric neurology, 2021) https://pubmed.ncbi.nlm.nih.gov/34153815/
• [3] Revascularization with drug-coated balloons only in complex coronary artery disease: a systematic review. (Clinical research in cardiology : official journal of the German Cardiac Society, 2026) https://pubmed.ncbi.nlm.nih.gov/42329403/
• [4] Pediatric sickle cell anemia: past achievements and future challenges. (Pediatric research, 2017) https://pubmed.ncbi.nlm.nih.gov/27706129/
• [5] Pan-JAK inhibitor delgocitinib cream demonstrates dose-dependent response in chronic hand eczema in a 16-week phase IIb randomized trial. (The British journal of dermatology, 2022) https://pubmed.ncbi.nlm.nih.gov/35084738/
• [6] Comparative effectiveness of advanced therapies for moderately to severely active ulcerative colitis: A 2024 American Gastroenterological Association Evidence Synthesis. (Gastroenterology, 2024) https://pubmed.ncbi.nlm.nih.gov/39425738/
• [7] AGA Technical Review on the Management of Moderate-to-Severe Ulcerative Colitis. (Gastroenterology, 2019) https://pubmed.ncbi.nlm.nih.gov/30576642/
• [8] Autoimmune diseases and sickle cell anemia: "Intersecting pathways and differential diagnosis". (British journal of haematology, 2022) https://pubmed.ncbi.nlm.nih.gov/35244209/

Disclaimer: The information provided in this article is for reference purposes only and is not intended for self-diagnosis or self-treatment. Always consult a qualified physician for diagnosis and the selection of optimal treatment tactics.